MedCap AB (publ)

Stockholm Stock Exchange MCAP.ST

MedCap AB (publ) Gross Profit for the year ending December 31, 2023: USD 91.44 M

MedCap AB (publ) Gross Profit is USD 91.44 M for the year ending December 31, 2023, a 107.06% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.
  • MedCap AB (publ) Gross Profit for the year ending December 31, 2022 was USD 44.16 M, a 8.46% change year over year.
  • MedCap AB (publ) Gross Profit for the year ending December 31, 2021 was USD 40.71 M, a 2.86% change year over year.
  • MedCap AB (publ) Gross Profit for the year ending December 31, 2020 was USD 39.58 M, a 28.29% change year over year.
  • MedCap AB (publ) Gross Profit for the year ending December 31, 2019 was USD 30.86 M, a 10.20% change year over year.
Key data
Date Gross Profit Operating Income EBIT EBITDA
Market news
Loading...
SV Wall Street
Stockholm Stock Exchange: MCAP.ST

MedCap AB (publ)

CEO Mr. Anders Dahlberg
IPO Date Nov. 9, 2007
Location Sweden
Headquarters Sundbybergsvägen 1
Employees 534
Sector Finance
Industries
Description

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, and pharmaceuticals companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Northern Europe. It typically invests between SEK25 million ($2.75 million) to SEK150 million ($16.51 million) with enterprise value and sales revenue between SEK50 million ($5.90 million) to SEK200 million ($23.06 million) and EBITDA between SEK1 million ($0.11 million) to SEK50 million ($5.50 million). The firm seeks to acquire stakes between 20% and 50% in its portfolio companies. It uses its capital and loans and makes balance sheet investments. MedCap AB (publ) was founded in 2001 and is based in Stockholm, Sweden.

Similar companies

BIOT.ST

Biotage AB (publ)

USD 12.62

3.34%

IVSO.ST

Invisio AB (publ)

USD 29.96

1.49%

ALIF-B.ST

AddLife AB (publ)

USD 13.60

3.54%

VITR.ST

Vitrolife AB (publ)

USD 20.09

1.26%

CEVI.ST

CellaVision AB (publ)

USD 19.86

5.09%

StockViz Staff

January 30, 2025

Any question? Send us an email